focus -WSS

focus

author：focus 2025-08-03 10:46:54 - browse：8965

A man enters the Regeneron Clinic at a monoclonal antibody treatment site in Pembroke Pines, Florida – politics and policy coverage from STAT — Regeneron agreed to price limits for a new Covid-19 drug that will be developed in partnership with the Department of Health and Human Services. CHANDAN KHANNA/AFP via Getty Images

WASHINGTON — A groundbreaking clause in a new deal between the Department of Health and Human Services and the pharmaceutical company Regeneron marks the first time the Biden administration has directly used its leverage to challenge drugmakers’ list prices, experts told STAT.

The contract between Regeneron and the government requires that the list price for a future monoclonal antibody drug to prevent Covid-19 is the same or lower in the United States as in other high-income countries. The release doesn’t explain which countries the government will be comparing prices with, or how pricing data will be determined.

The deal was part of the White House’s Project NextGen initiative, which includes $5 billion in new vaccines and therapies. HHS announced that it is spending $326 million to help Regeneron develop a new monoclonal antibody to prevent Covid-19. Regeneron in January announced plans to start testing a potentially variant-proof antibody, which is set to go into clinical trials later this year.

Get unlimited access to award-winning journalism and exclusive events.

Subscribe Log In

Previous article： Virginia high school admissions case could be legal follow
Next article： Bird flu in milk supply is likely coming from asymptomatic cows

entertainment

WSS

Health care needs a new profession: neuroimaging counseling

Cancer researcher Catriona Jamieson is sending tumors into space

Getting Alzheimer's drug Leqembi to patients can be a challenge

Novel spinal cord stimulator treats paralysis without surgery

Has Bernie Sanders reached the limit of his pharma bullying effort?

GSK’s asthma push continues as drug succeeds in Phase 3 trials

explore

focus

entertainment

Novavax promises a turnaround & Lilly roils the obesity market

Black vets could get higher VA benefits if race not used in lung test

How one medical school became remarkably diverse

The creative science of coining drug names

Alkermes shareholders re

Brain MRIs reveal impact of 'toxic stress' on Black children

Indiana Supreme Court upholds abortion ban, says state constitution gives only limited protections

Health care needs a new profession: neuroimaging counseling

Wildfire smoke exposes gaps in outdoor worker protections

H5N1 bird flu virus started spreading in cows in Texas in December

leisure time

As health system earnings go up, health insurance stocks go down

Orangutan used medicinal plant to treat wound, first time ever seen

Lawmakers grill UnitedHealth CEO on Change cyberattack

UnitedHealth financials solid despite Change Healthcare cyberattack

Orangutan used medicinal plant to treat wound, first time ever seen

Has Bernie Sanders reached the limit of his pharma bullying effort?

Wikipedia

Wikipedia

entertainment

hotspot